124 related articles for article (PubMed ID: 4715065)
1. Management of neuritis in leprosy.
Pfaltzgraff RE
Trop Doct; 1973 Jul; 3(3):138-9. PubMed ID: 4715065
[No Abstract] [Full Text] [Related]
2. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472
[No Abstract] [Full Text] [Related]
3. [Lampren in the treatment of leprosy].
Ahrens T
Schweiz Rundsch Med Prax; 1970 Mar; 59(11):387-9. PubMed ID: 5519711
[No Abstract] [Full Text] [Related]
4. Clofazimine (B663, Geigy) in leprosy reactions.
Smith RB
Australas J Dermatol; 1972 Apr; 13(1):31-5. PubMed ID: 5082494
[No Abstract] [Full Text] [Related]
5. [Trial of a new leprostatics (B-663) in the treatment of lepromatous leprosy].
Renders A
Ann Soc Belges Med Trop Parasitol Mycol; 1968; 48(6):625-35. PubMed ID: 5759964
[No Abstract] [Full Text] [Related]
6. Chemotherapy of leprosy.
Leiker DL
Int J Lepr Other Mycobact Dis; 1971; 39(2):462-6. PubMed ID: 4948084
[No Abstract] [Full Text] [Related]
7. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
[No Abstract] [Full Text] [Related]
8. The treatment of leprosy and its acute complications.
Jopling WH
Trop Doct; 1973 Jan; 3(1):8-11. PubMed ID: 4120944
[No Abstract] [Full Text] [Related]
9. The control of neuritis in leprosy with clofazimine.
Pfaltzgraff RE
Int J Lepr Other Mycobact Dis; 1972; 40(4):392-8. PubMed ID: 4586401
[No Abstract] [Full Text] [Related]
10. Correlation of laboratory and clinical data during treatment of leprosy.
Pattyn SR; Rollier R; Rollier MR; De Muynck A; Janssens PG; Verdoolaeghe-Van Loo G
Ann Soc Belg Med Trop; 1972; 52(6):537-48. PubMed ID: 4574223
[No Abstract] [Full Text] [Related]
11. Therapy of leprosy.
Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; MartÃnez DomÃnguez V
Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056
[TBL] [Abstract][Full Text] [Related]
12. [Randomized controlled trial of medical and medico-surgical treatment of Hansen's neuritis].
Boucher P; Millan J; Parent M; Moulia-Pela JP
Acta Leprol; 1999; 11(4):171-7. PubMed ID: 10987048
[TBL] [Abstract][Full Text] [Related]
13. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)).
Schulz EJ
Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819
[No Abstract] [Full Text] [Related]
14. Lamprene: first results of treatment in the Netherlands in a group of 6 leprosy patients.
Hogerzeil LM
Dermatologica; 1971; 143(6):339-44. PubMed ID: 5150817
[No Abstract] [Full Text] [Related]
15. Clofazimine in leprosy.
Schulz EJ
Br Med J; 1972 Mar; 1(5802):749. PubMed ID: 5015339
[No Abstract] [Full Text] [Related]
16. Motor conduction velocity studies in patients with leprosy reaction treated with thalidomide and other drugs.
Sheskin J; Magora A; Sagher F
Int J Lepr Other Mycobact Dis; 1969; 37(4):359-64. PubMed ID: 4918201
[No Abstract] [Full Text] [Related]
17. Treatment of leprosy with a phenazine derivative (B 663 or G 30 320)--clofazimine.
Gatti JC; Cardama JE; Balina LM; Crespi HG; Bianchi O; Santabaya E; Farina MH
Lepr Rev; 1970 Apr; 41(2):89-92. PubMed ID: 5453084
[No Abstract] [Full Text] [Related]
18. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report.
Devadason C
Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239
[No Abstract] [Full Text] [Related]
19. The condition of the peripheral nerve in leprosy under various forms of treatment. Conduction velocity studies in long-term follow-up.
Magora A; Sheskin J; Sagher F; Gonen B
Int J Lepr Other Mycobact Dis; 1970; 38(2):149-63. PubMed ID: 5529246
[No Abstract] [Full Text] [Related]
20. The use of B 663 (clofazimine) in the treatment of Chinese leprosy patients with chronic reaction.
Warren AG
Lepr Rev; 1970 Apr; 41(2):74-82. PubMed ID: 5453082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
